These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2519 related articles for article (PubMed ID: 30809081)
1. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
2. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran. Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109 [TBL] [Abstract][Full Text] [Related]
3. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis. Liu D Cell Oncol (Dordr); 2019 Apr; 42(2):197-209. PubMed ID: 30645729 [TBL] [Abstract][Full Text] [Related]
4. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior. Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750 [TBL] [Abstract][Full Text] [Related]
5. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer. Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414 [TBL] [Abstract][Full Text] [Related]
6. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases]. Gao J; Sun ZW; Li YY; Shen L Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823 [TBL] [Abstract][Full Text] [Related]
7. Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations. Holck S; Bonde J; Pedersen H; Petersen AA; Chaube A; Nielsen HJ; Larsson LI Hum Pathol; 2016 Aug; 54():37-46. PubMed ID: 27036313 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy. Llovet P; Sastre J; Ortega JS; Bando I; Ferrer M; García-Alfonso P; Donnay O; Carrato A; Jiménez A; Aranda E; León A; Grávalos C; Cámara JC; Feliú J; Sanchíz B; Caldés T; Díaz-Rubio E Mol Diagn Ther; 2015 Dec; 19(6):397-408. PubMed ID: 26341080 [TBL] [Abstract][Full Text] [Related]
9. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients. Jin M; Long ZW; Yang J; Lin X Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432 [TBL] [Abstract][Full Text] [Related]
10. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors. Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831 [TBL] [Abstract][Full Text] [Related]
11. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002 [TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers. Temraz S; Mukherji D; Shamseddine A Int J Mol Sci; 2015 Sep; 16(9):22976-88. PubMed ID: 26404261 [TBL] [Abstract][Full Text] [Related]
13. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling. Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572 [TBL] [Abstract][Full Text] [Related]
14. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis. Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109 [TBL] [Abstract][Full Text] [Related]
15. Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases. Ates O; Yalcin S Indian J Cancer; 2019; 56(2):176-179. PubMed ID: 31062740 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related]